Related Experiment Video

Updated: Jul 30, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.7K

Uveitis in pediatric inflammatory bowel disease

Kimberley Yu1, Stefanie Davidson2, Gil Binenbaum2

  • 1University of Southern California Roski Eye Institute, Los Angeles, California.

Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|May 18, 2023
PubMed

Insights

Uveitis (eye inflammation) is rare in children with inflammatory bowel disease (IBD), affecting only 1.6% in this study. When it occurs, uveitis in pediatric IBD patients is typically symptomatic.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Gastroenterology

Background:

  • No established uveitis screening guidelines exist for pediatric patients with inflammatory bowel disease (IBD).
  • Uveitis is a potential extraintestinal manifestation of IBD.
  • Early detection and management of uveitis are crucial in children with IBD.

Observation:

  • Retrospective cohort study analyzing ophthalmologist examinations in children with IBD over 12 years.
  • Data included 315 children with IBD (mean age 11.7 years) and 974 eye examinations.
  • Prevalence, age at onset, and clinical characteristics of uveitis were assessed.

Findings:

  • Uveitis was diagnosed in 1.6% (95% CI, 0.7%-3.7%) of pediatric IBD patients.
  • The mean age of uveitis onset was 14.3 years.
  • Uveitis occurred in 1.4% of Crohn's disease, 3.6% of IBD-unclassified, and 0% of ulcerative colitis cases; all cases were symptomatic.

Implications:

  • Uveitis appears to be a rare complication in pediatric IBD.
  • Symptomatic presentation is characteristic of uveitis in this population.
  • Further research may inform the development of targeted screening protocols for pediatric IBD patients at risk for uveitis.

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.9K
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

8.9K

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
312
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
175
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
228
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
160
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
494
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
369